High Sierra Technologies, Inc. (HSTI)
USD 1.0
(-9.09%)
USD 1.0
(-9.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 238.36 Thousand USD | -6.86% |
| 2021 | 255.92 Thousand USD | -0.77% |
| 2020 | 257.91 Thousand USD | 19.55% |
| 2019 | 215.73 Thousand USD | 519.29% |
| 2018 | 34.83 Thousand USD | 57.49% |
| 2017 | 22.11 Thousand USD | 7.05% |
| 2016 | 20.66 Thousand USD | -40.7% |
| 2015 | 34.84 Thousand USD | 44.3% |
| 2014 | 24.14 Thousand USD | 1.5% |
| 2013 | 23.78 Thousand USD | 4.5% |
| 2012 | 22.76 Thousand USD | 2.69% |
| 2011 | 22.16 Thousand USD | 22.81% |
| 2010 | 18.05 Thousand USD | -3.29% |
| 2009 | 18.66 Thousand USD | 4.3% |
| 2008 | 17.89 Thousand USD | -15.34% |
| 2007 | 21.13 Thousand USD | -29.01% |
| 2006 | 29.77 Thousand USD | 237.82% |
| 2005 | 8813.00 USD | 193.91% |
| 2004 | -9385.00 USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q1 | 75.21 Thousand USD | 5.97% |
| 2023 Q2 | 77.11 Thousand USD | 2.52% |
| 2023 Q3 | 73.2 Thousand USD | -5.07% |
| 2022 Q1 | 97.93 Thousand USD | 414.93% |
| 2022 FY | 238.36 Thousand USD | -6.86% |
| 2022 Q4 | 70.98 Thousand USD | 103.54% |
| 2022 Q3 | 34.87 Thousand USD | 0.86% |
| 2022 Q2 | 34.57 Thousand USD | -64.69% |
| 2021 Q1 | 70.25 Thousand USD | -62.62% |
| 2021 Q4 | 19.01 Thousand USD | -84.08% |
| 2021 FY | 255.92 Thousand USD | -0.77% |
| 2021 Q2 | 47.22 Thousand USD | -32.78% |
| 2021 Q3 | 119.42 Thousand USD | 152.89% |
| 2020 Q1 | 17.39 Thousand USD | 106.0% |
| 2020 Q3 | 33.11 Thousand USD | 70.31% |
| 2020 Q2 | 19.44 Thousand USD | 11.82% |
| 2020 FY | 257.91 Thousand USD | 19.55% |
| 2020 Q4 | 187.95 Thousand USD | 467.51% |
| 2019 FY | 215.73 Thousand USD | 519.29% |
| 2019 Q3 | 172.24 Thousand USD | -37.7% |
| 2019 Q1 | 56.82 Thousand USD | 33.65% |
| 2019 Q2 | 276.49 Thousand USD | 386.55% |
| 2019 Q4 | -289.84 Thousand USD | -268.27% |
| 2018 Q4 | 42.52 Thousand USD | 58.89% |
| 2018 Q1 | 90.00 USD | -97.36% |
| 2018 Q3 | 26.76 Thousand USD | 177.98% |
| 2018 Q2 | 9627.00 USD | 10596.67% |
| 2018 FY | 34.83 Thousand USD | 57.49% |
| 2017 Q3 | 3666.00 USD | -67.67% |
| 2017 FY | 22.11 Thousand USD | 7.05% |
| 2017 Q4 | 3414.00 USD | -6.87% |
| 2017 Q2 | 11.33 Thousand USD | 206.29% |
| 2017 Q1 | 3702.00 USD | 1.65% |
| 2016 Q4 | 3642.00 USD | -31.71% |
| 2016 Q3 | 5333.00 USD | -42.61% |
| 2016 FY | 20.66 Thousand USD | -40.7% |
| 2016 Q2 | 9293.00 USD | 287.85% |
| 2016 Q1 | 2396.00 USD | -56.74% |
| 2015 Q2 | 17.46 Thousand USD | 328.66% |
| 2015 Q1 | 4075.00 USD | -31.82% |
| 2015 Q4 | 5538.00 USD | -28.65% |
| 2015 FY | 34.84 Thousand USD | 44.3% |
| 2015 Q3 | 7762.00 USD | -55.56% |
| 2014 FY | 24.14 Thousand USD | 1.5% |
| 2014 Q4 | 5977.00 USD | -20.01% |
| 2014 Q3 | 7472.00 USD | 115.52% |
| 2014 Q2 | 3467.00 USD | -52.05% |
| 2014 Q1 | 7230.00 USD | 45.27% |
| 2013 Q1 | 2282.00 USD | -56.13% |
| 2013 Q2 | 10.81 Thousand USD | 373.75% |
| 2013 Q3 | 5719.00 USD | -47.1% |
| 2013 Q4 | 4977.00 USD | -12.97% |
| 2013 FY | 23.78 Thousand USD | 4.5% |
| 2012 FY | 22.76 Thousand USD | 2.69% |
| 2012 Q3 | 6735.00 USD | 33.23% |
| 2012 Q2 | 5055.00 USD | -12.45% |
| 2012 Q4 | 5202.00 USD | -22.76% |
| 2012 Q1 | 5774.00 USD | -8.54% |
| 2011 Q1 | 7055.00 USD | 80.11% |
| 2011 Q2 | 4670.00 USD | -33.81% |
| 2011 Q3 | 4130.00 USD | -11.56% |
| 2011 FY | 22.16 Thousand USD | 22.81% |
| 2011 Q4 | 6313.00 USD | 52.86% |
| 2010 Q3 | 3204.00 USD | -52.18% |
| 2010 Q2 | 6700.00 USD | 58.47% |
| 2010 Q1 | 4228.00 USD | 11.97% |
| 2010 FY | 18.05 Thousand USD | -3.29% |
| 2010 Q4 | 3917.00 USD | 22.25% |
| 2009 Q3 | 3384.00 USD | -33.19% |
| 2009 Q2 | 5065.00 USD | -21.34% |
| 2009 Q1 | 6439.00 USD | 111.88% |
| 2009 Q4 | 3776.00 USD | 11.58% |
| 2009 FY | 18.66 Thousand USD | 4.3% |
| 2008 Q1 | 5136.00 USD | 70.18% |
| 2008 Q4 | 3039.00 USD | -1.07% |
| 2008 Q3 | 3072.00 USD | -53.79% |
| 2008 Q2 | 6648.00 USD | 29.44% |
| 2008 FY | 17.89 Thousand USD | -15.34% |
| 2007 Q1 | 6756.00 USD | 192.97% |
| 2007 Q2 | 8467.00 USD | 25.33% |
| 2007 FY | 21.13 Thousand USD | -29.01% |
| 2007 Q3 | 2896.00 USD | -65.8% |
| 2007 Q4 | 3018.00 USD | 4.21% |
| 2006 Q4 | 2306.00 USD | -72.89% |
| 2006 Q3 | 8506.00 USD | -53.4% |
| 2006 Q1 | -1017.00 USD | 75.37% |
| 2006 FY | 29.77 Thousand USD | 237.82% |
| 2006 Q2 | 18.25 Thousand USD | 1894.79% |
| 2005 Q1 | -1364.00 USD | 0.0% |
| 2005 Q2 | -5565.00 USD | -307.99% |
| 2005 Q3 | -1359.00 USD | 75.58% |
| 2005 Q4 | -4129.00 USD | -203.83% |
| 2005 FY | 8813.00 USD | 193.91% |
| 2004 FY | -9385.00 USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BioQuest Corp. | 89.76 USD | -265457.041% |
| GSRX Industries Inc. | - USD | -Infinity% |
| Instadose Pharma Corp. | - USD | -Infinity% |